查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1459785

神经科学市场 - 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Neuroscience Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 182 Pages | 商品交期: 2-10个工作天内

价格

神经科学市场 - 报告范围

TMR 关于全球神经科学市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了该期间全球神经科学市场的收入2017-2031年，以2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球神经科学市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解神经科学市场。

市场概况
2022年市场价​​值 301 亿美元
2031 年市场价值 416 亿美元
CAGR 3.7%

该报告深入研究了全球神经科学市场的竞争格局。全球神经科学市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球神经科学市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：按组成部分

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按组成部分，2017-2031
    • 乐器
    • 软体
    • 服务
  • 市场吸引力分析：按组成部分

第 7 章：全球市场分析与预测：依技术分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依技术分类，2017-2031
    • 全脑影像
    • 神经显微镜
    • 电生理学
    • 神经蛋白质体学分析
    • 动物行为分析
    • 神经功能分析
    • 其他的
  • 市场吸引力分析：依技术分类

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 医院
    • 诊断实验室
    • 学术研究机构
    • 其他的
  • 市场吸引力分析：依技术分类

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • NEURALINK
    • Kernel
    • BrainCo, Inc.
    • MindMaze
    • Paradromics
    • NeuroPro
    • NeuroSky
    • EMOTIV, Inc.
    • Cercare Medical A/S
    • Plexon, Inc.
    • Noldus Information Technology BV
    • Femtonics Ltd.
    • Neuralynx, Inc.
    • Neurable, Inc.
    • Bitbrain Technologies
    • Halo
    • NeuroNexus Technologies, Inc.
Product Code: TMRGL49641

Neuroscience Market - Scope of Report

TMR's report on the global neurosciences market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global neurosciences market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurosciences market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the neurosciences market.

Market Snapshot
Market Value in 2022US$ 30.1 Bn
Market Value in 2031US$ 41.6 Bn
CAGR3.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global neurosciences market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global neurosciences market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurosciences market.

The report delves into the competitive landscape of the global neurosciences market. Key players operating in the global neurosciences market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global neurosciences market profiled in this report.

Key Questions Answered in Global neurosciences Market Report:

  • What is the sales/revenue generated by neurosciences across all regions during the forecast period?
  • What are the opportunities in the global neurosciences market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Neuroscience Market - Research Objectives and Research Approach

The comprehensive report on the global neurosciences market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global neurosciences market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global neurosciences market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Neuroscience Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Neuroscience Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Neuroscience Market Analysis and Forecast, by Component

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Component, 2017-2031
    • 6.3.1. Instrument
    • 6.3.2. Software
    • 6.3.3. Services
  • 6.4. Market Attractiveness Analysis, by Component

7. Global Neuroscience Market Analysis and Forecast, by Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2017-2031
    • 7.3.1. Whole Brain Imaging
    • 7.3.2. Neuro-microscopy
    • 7.3.3. Electrophysiology
    • 7.3.4. Neuroproteomics Analysis
    • 7.3.5. Animal Behavior Analysis
    • 7.3.6. Neuro-functional Analysis
    • 7.3.7. Others
  • 7.4. Market Attractiveness Analysis, by Technology

8. Global Neuroscience Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Academic & Research Institutions
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Technology

9. Global Neuroscience Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Neuroscience Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Component, 2017-2031
    • 10.3.1. Instrument
    • 10.3.2. Software
    • 10.3.3. Services
  • 10.4. Market Value Forecast, by Technology, 2017-2031
    • 10.4.1. Whole Brain Imaging
    • 10.4.2. Neuro-microscopy
    • 10.4.3. Electrophysiology
    • 10.4.4. Neuroproteomics Analysis
    • 10.4.5. Animal Behavior Analysis
    • 10.4.6. Neuro-functional Analysis
    • 10.4.7. Others
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Hospitals
    • 10.5.2. Diagnostic Laboratories
    • 10.5.3. Academic & Research Institutions
    • 10.5.4. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Component
    • 10.7.2. By Technology
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Neuroscience Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Component, 2017-2031
    • 11.3.1. Instrument
    • 11.3.2. Software
    • 11.3.3. Services
  • 11.4. Market Value Forecast, by Technology, 2017-2031
    • 11.4.1. Whole Brain Imaging
    • 11.4.2. Neuro-microscopy
    • 11.4.3. Electrophysiology
    • 11.4.4. Neuroproteomics Analysis
    • 11.4.5. Animal Behavior Analysis
    • 11.4.6. Neuro-functional Analysis
    • 11.4.7. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Laboratories
    • 11.5.3. Academic & Research Institutions
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Component
    • 11.7.2. By Technology
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Neuroscience Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Component, 2017-2031
    • 12.3.1. Instrument
    • 12.3.2. Software
    • 12.3.3. Services
  • 12.4. Market Value Forecast, by Technology, 2017-2031
    • 12.4.1. Whole Brain Imaging
    • 12.4.2. Neuro-microscopy
    • 12.4.3. Electrophysiology
    • 12.4.4. Neuroproteomics Analysis
    • 12.4.5. Animal Behavior Analysis
    • 12.4.6. Neuro-functional Analysis
    • 12.4.7. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostic Laboratories
    • 12.5.3. Academic & Research Institutions
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Component
    • 12.7.2. By Technology
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Neuroscience Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Component, 2017-2031
    • 13.3.1. Instrument
    • 13.3.2. Software
    • 13.3.3. Services
  • 13.4. Market Value Forecast, by Technology, 2017-2031
    • 13.4.1. Whole Brain Imaging
    • 13.4.2. Neuro-microscopy
    • 13.4.3. Electrophysiology
    • 13.4.4. Neuroproteomics Analysis
    • 13.4.5. Animal Behavior Analysis
    • 13.4.6. Neuro-functional Analysis
    • 13.4.7. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostic Laboratories
    • 13.5.3. Academic & Research Institutions
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Component
    • 13.7.2. By Technology
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Neuroscience Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Component, 2017-2031
    • 14.3.1. Instrument
    • 14.3.2. Software
    • 14.3.3. Services
  • 14.4. Market Value Forecast, by Technology, 2017-2031
    • 14.4.1. Whole Brain Imaging
    • 14.4.2. Neuro-microscopy
    • 14.4.3. Electrophysiology
    • 14.4.4. Neuroproteomics Analysis
    • 14.4.5. Animal Behavior Analysis
    • 14.4.6. Neuro-functional Analysis
    • 14.4.7. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostic Laboratories
    • 14.5.3. Academic & Research Institutions
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Component
    • 14.7.2. By Technology
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. NEURALINK
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Kernel
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. BrainCo, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. MindMaze
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Paradromics
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. NeuroPro
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. NeuroSky
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. EMOTIV, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Cercare Medical A/S
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Plexon, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Noldus Information Technology B.V.
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Femtonics Ltd.
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview
    • 15.3.13. Neuralynx, Inc.
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. SWOT Analysis
      • 15.3.13.4. Financial Overview
      • 15.3.13.5. Strategic Overview
    • 15.3.14. Neurable, Inc.
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Product Portfolio
      • 15.3.14.3. SWOT Analysis
      • 15.3.14.4. Financial Overview
      • 15.3.14.5. Strategic Overview
    • 15.3.15. Bitbrain Technologies
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Product Portfolio
      • 15.3.15.3. SWOT Analysis
      • 15.3.15.4. Financial Overview
      • 15.3.15.5. Strategic Overview
    • 15.3.16. Halo Neuroscience
      • 15.3.16.1. Company Overview
      • 15.3.16.2. Product Portfolio
      • 15.3.16.3. SWOT Analysis
      • 15.3.16.4. Financial Overview
      • 15.3.16.5. Strategic Overview
    • 15.3.17. NeuroNexus Technologies, Inc.
      • 15.3.17.1. Company Overview
      • 15.3.17.2. Product Portfolio
      • 15.3.17.3. SWOT Analysis
      • 15.3.17.4. Financial Overview
      • 15.3.17.5. Strategic Overview

List of Tables

  • Table 01: Global Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 02: Global Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 03: Global Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Neuroscience Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Neuroscience Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 07: North America Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 08: North America Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 11: Europe Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 12: Europe Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 15: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 16: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 19: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 20: Latin America Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 23: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 24: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Neuroscience Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Neuroscience Market Revenue (US$ Mn), by Component, 2022
  • Figure 03: Global Neuroscience Market Value Share, by Component, 2022
  • Figure 04: Global Neuroscience Market Revenue (US$ Mn), by Technology, 2022
  • Figure 05: Global Neuroscience Market Value Share, by Technology, 2022
  • Figure 06: Global Neuroscience Market Revenue (US$ Mn), by End-user, 2022
  • Figure 07: Global Neuroscience Market Value Share, by End-user, 2022
  • Figure 08: Global Neuroscience Market Value Share, by Region, 2022
  • Figure 09: Global Neuroscience Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 11: Global Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 12: Global Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 13: Global Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 14: Global Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 15: Global Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 16: Global Neuroscience Market Value Share Analysis, by Region, 2022-2031
  • Figure 17: Global Neuroscience Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Neuroscience Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Neuroscience Market Value Share Analysis, by Country, 2022-2031
  • Figure 21: North America Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 22: North America Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 23: North America Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 24: North America Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 25: North America Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 26: North America Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Europe Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 30: Europe Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 31: Europe Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 32: Europe Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 33: Europe Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 34: Europe Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 35: Europe Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: Asia Pacific Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 39: Asia Pacific Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 40: Asia Pacific Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 41: Asia Pacific Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 42: Asia Pacific Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 43: Asia Pacific Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 44: Asia Pacific Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Latin America Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 48: Latin America Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 49: Latin America Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 50: Latin America Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 51: Latin America Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 52: Latin America Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 53: Latin America Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 57: Middle East & Africa Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 58: Middle East & Africa Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 59: Middle East & Africa Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 60: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 61: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 62: Middle East & Africa Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031